THERAVANCE BIOPHARMA INC's ticker is and the CUSIP is 88339KAA0. A total of 22 filers reported holding THERAVANCE BIOPHARMA INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $539,000 | -54.9% | 580,000 | -53.6% | 0.05% | -51.4% |
| Q1 2022 | $1,194,000 | +2.7% | 1,250,000 | 0.0% | 0.10% | +2.9% |
| Q3 2021 | $1,163,000 | -61.6% | 1,250,000 | -60.7% | 0.10% | -62.5% |
| Q2 2021 | $3,031,000 | -6.6% | 3,182,000 | 0.0% | 0.27% | -29.0% |
| Q1 2021 | $3,246,000 | -9.4% | 3,182,000 | -15.7% | 0.38% | -13.0% |
| Q4 2020 | $3,584,000 | +6.4% | 3,773,000 | 0.0% | 0.44% | +0.5% |
| Q3 2020 | $3,367,000 | -41.8% | 3,773,000 | -36.3% | 0.44% | -45.6% |
| Q2 2020 | $5,790,000 | -20.0% | 5,923,000 | -18.6% | 0.80% | -7.3% |
| Q1 2020 | $7,237,000 | -59.0% | 7,273,000 | -57.2% | 0.87% | -40.8% |
| Q4 2019 | $17,664,000 | -0.1% | 16,985,000 | -10.9% | 1.47% | +4.3% |
| Q3 2019 | $17,683,000 | +10.0% | 19,065,000 | +2.9% | 1.41% | -0.8% |
| Q2 2019 | $16,075,000 | -14.2% | 18,530,000 | -3.6% | 1.42% | -19.8% |
| Q1 2019 | $18,725,000 | +1.0% | 19,230,000 | +6.8% | 1.77% | -11.8% |
| Q4 2018 | $18,539,000 | -12.4% | 18,010,000 | +0.6% | 2.00% | +9.3% |
| Q3 2018 | $21,161,000 | +20.0% | 17,895,000 | 0.0% | 1.83% | +30.6% |
| Q2 2018 | $17,627,000 | -8.3% | 17,895,000 | -5.5% | 1.40% | +13.4% |
| Q1 2018 | $19,221,000 | +6.1% | 18,937,000 | +14.7% | 1.24% | +15.9% |
| Q4 2017 | $18,114,000 | +80.7% | 16,505,000 | +102.0% | 1.07% | +108.2% |
| Q3 2017 | $10,024,000 | – | 8,170,000 | – | 0.51% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 6,000,000 | $5,827,000 | 3.55% |
| DeepCurrents Investment Group LLC | 21,223,000 | $20,803,000 | 1.80% |
| ZAZOVE ASSOCIATES LLC | 19,230,000 | $18,725,000 | 1.77% |
| Mohican Financial Management, LLC | 500,000 | $494,000 | 1.61% |
| Castle Creek Arbitrage, LLC | 5,149,000 | $5,015,000 | 1.47% |
| LINDEN ADVISORS LP | 62,688,000 | $61,071,000 | 1.40% |
| Verition Fund Management LLC | 10,817,000 | $10,504,000 | 0.41% |
| WOLVERINE ASSET MANAGEMENT LLC | 24,100,000 | $23,451,000 | 0.32% |
| Baupost Group | 30,000,000 | $29,213,000 | 0.24% |
| SSI INVESTMENT MANAGEMENT LLC | 2,763,000 | $2,676,000 | 0.22% |